ClinicalTrials.gg
Not yet recruitingNCT06256952ReCoDeUpdated Aug 28, 2024

Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use

An interventional study of PIT paradigm and social exclusion (Cyberball task) in Alcohol Use Disorder, Alcoholism and Stress Reaction, sponsored by Charite University, Berlin, Germany. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-28.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Alcoholism by Charite University, Berlin, Germany — 4 open to participants now, 4 under way, none of them phase 3. Alcoholism · Charite University, Berlin, Germany.

Started
2024
with 2 others
No phase
5 of 14
3 open now
Registered
10th of 14
by date

Among the 14 studies in Alcoholism by Charite University, Berlin, Germany, this one is one of 3 that started in 2024, is one of 5 with no phase, and was the 10th registered.

Alcoholism

1,678 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

4 of the 14 studies in Alcoholism by Charite University, Berlin, Germany are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Alcoholism by Charite University, Berlin, Germany, or all of them as a file.
02

Study summary

During the first funding period (1st FP) we investigated the impact of acute and chronic stress (Trier Social Stress Test, TSST) on Pavlovian-to-instrumental transfer (PIT). Moreover, we developed a novel full transfer task that allows assessing both general and specific PIT to investigate whether specific PIT differs between alcohol use disorder (AUD) and control subjects. We found that our online version of TSST induced stress and thereby amplified PIT effects in participants. Preliminary analyses of the full transfer task indicate that AUD participants exhibit a stronger specific PIT effect compared to controls. Based on these findings, we want to assess the following aim for this study:

Investigate the effect of experimentally induced social exclusion on alcohol-specific and general PIT effects in AUD and control participants.

Read the detailed description

The projects research aim:

The investigators will examine how an experimentally induced social exclusion by the Cyberball task is associated with alcohol specific and general PIT effects by using the newly developed full transfer task from 1st funding period in AUD vs. HCs.

The investigators will use the newly developed full PIT paradigm to examine the modifying effect of experimentally induced social exclusion stress on alcohol-specific and general PIT effects. While using the Trier Social Stress Test in the 1st FP, the investigators now want to go one step further by including social exclusion/ostracism to the stress component, which has not been studied in association with PIT effects yet. The investigators here want to shed light on possible underlying mechanisms which can lead to a promotion of alcohol-seeking by alcohol-stimuli in situations of social exclusion.

Participants (50 AUD and 50 HC) will be assessed at two time points, once after experimentally induced social exclusion and once after social inclusion in a fully balanced, cross-over within-subject design. Subjects will play an online game tossing a ball to each other with two more virtual co-players (Cyberball). Using a cover story, we make subjects believe that the co-players really exist and that they play a live online game. During social exclusion, subjects will be systematically excluded by one co-player (partial exclusion), and during social inclusion, ball tosses will be balanced between all three players. Cyberball usually induces feelings of social isolation and altered behavioral reactions in the subject, which the investigators want to assess by analyzing ball tossing behavior over time, as well as physiological and subjective measures (concentration of cortisol in saliva, heart rate variability and emotions questionnaires, such as the Need to Belong Scale, Rejection Sensitivity Questionnaire, Need threat scale and Positive and Negative Affect Schedule pre and post Cyberball game and after PIT). After the Cyberball experiment, subjects will undergo the transfer part of the full PIT task (using a parallel version at one of the two days in a randomized order).

Hypothesis 1a:

Social exclusion will lead to a stronger stress hormone response (concentration of cortisol in saliva), lower heart rate variability and a stronger general PIT effect compared to social inclusion (main effect social exclusion intervention on PIT).

Hypothesis 1b:

Stronger social exclusion effects in AUD subjects compared to controls will lead to stronger PIT effects compared to social inclusion (interaction effect between group and stress intervention on PIT), especially for alcohol-specific PIT.

03

Conditions studied

  • Alcohol Use Disorder
  • Alcoholism
  • Stress Reaction
  • Ostracism
  • Substance Use Disorders

Keywords

  • Substance use disorder (SUD)
  • Alcohol use disorder (AUD)
  • General and outcome-specific Pavlovian to instrumental transfer
  • Social exclusion
  • Humans
  • Surveys and Questionnaires
  • Reward
  • Cues
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males and females between 18-65 years of age,
  • AUD subjects: meet 4 or more criteria for alcohol-use disorder (not requiring withdrawal as assessed by an independent psychiatrist),
  • Currently using alcohol without a desire for abstinence,
  • Ability to consent to the study and complete the questionnaires.
  • Sufficient language skills: German
  • Availability between 3pm-6pm on 2 consecutive days,
  • existing health insurance

Exclusion criteria

Exclusion Criteria:

  • Lifetime diagnosis according to DMS-5 for a: Bipolar disorder, schizophrenia, schizophrenia spectrum disorder, substance dependence except for alcohol, nicotine, cannabis, and/or methamphetamine
  • Currently meeting diagnostic criteria for depressive episode, suicidal ideation,
  • History of traumatic brain injury or severe neurological disease (such as dementia, Parkinson's disease, multiple sclerosis)
  • Pregnancy or breastfeeding,
  • Ingestion of medications known to interact with the CNS in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test),
  • Color vision deficiency
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Control (HC) - exclusion first

    Healthy participants without SUD Cyberball: Exclusion Day 1; Cyberball: Inclusion Day 2

    Behavioral: PIT paradigm · Behavioral: social exclusion (Cyberball task) · Diagnostic Test: Saliva samples · Diagnostic Test: basic psychological assessment · Diagnostic Test: pre and post cyberball task · Diagnostic Test: VAS · Diagnostic Test: after cyberball task · Behavioral: social inclusion (Cyberball task)

  • Experimental
    Control (HC) - inclusion first

    Healthy participants without SUD Cyberball: Inclusion Day 1; Cyberball: Exclusion Day 2

    Behavioral: PIT paradigm · Behavioral: social exclusion (Cyberball task) · Diagnostic Test: Saliva samples · Diagnostic Test: basic psychological assessment · Diagnostic Test: pre and post cyberball task · Diagnostic Test: VAS · Diagnostic Test: after cyberball task · Behavioral: social inclusion (Cyberball task)

  • Experimental
    Moderate to sever alcohol users (AUD) - exclusion first

    Participants with alcohol use disorder (moderate to severe if no withdrawal symptoms) and no other substance use disorder (SUD) Cyberball: Exclusion Day 1; Cyberball: Inclusion Day 2

    Behavioral: PIT paradigm · Behavioral: social exclusion (Cyberball task) · Diagnostic Test: Saliva samples · Diagnostic Test: basic psychological assessment · Diagnostic Test: pre and post cyberball task · Diagnostic Test: VAS · Diagnostic Test: after cyberball task · Behavioral: social inclusion (Cyberball task)

  • Experimental
    Moderate to sever alcohol users (AUD) - inclusion first

    Participants with alcohol use disorder (moderate to severe if no withdrawal symptoms) and no other substance use disorder (SUD) Cyberball: Inclusion Day 1; Cyberball: Exclusion Day 2

    Behavioral: PIT paradigm · Behavioral: social exclusion (Cyberball task) · Diagnostic Test: Saliva samples · Diagnostic Test: basic psychological assessment · Diagnostic Test: pre and post cyberball task · Diagnostic Test: VAS · Diagnostic Test: after cyberball task · Behavioral: social inclusion (Cyberball task)

Interventions

  • BehavioralPIT paradigm

    The paradigm consists of four parts: In the first part, an instrumental learning task is completed in which subjects must learn which stimuli require a response and which do not. In the second part, a classical (Pavlovian) conditioning task is then completed in which subjects learn by passive viewing which stimuli are associated with certain amounts of money. The third part measures to which instrumental responses (learned in Part 1) are modulated by the presentation of the classically conditioned stimuli (learned in Part 2). At the same time drug-associated stimuli are presented in the background measuring to which extent they conflict with the learned instrumental behavior. In the last part, query trials are implemented in which the participants have to choose between two pictures to assess the relative cue value.

  • Behavioralsocial exclusion (Cyberball task)

    Social exclusion will be assessed using the cyberball paradigm: subjects will play an online game tossing a ball to each other with two more virtual co-players. Using a cover story, we make subjects believe that the co-players really exist and that they play a live online game. During social exclusion, subjects will be systematically excluded by one co-player, and during social inclusion, ball tosses will be balanced between all three players.

  • Diagnostic testSaliva samples

    Assessing acute stress effects in AUD and HC subjects

  • Diagnostic testbasic psychological assessment

    * Sociodemographics * ASSIST * Quantity Frequency: Alcohol, tobacco/e-cigarette, Cannabis \& other illegal drugs * SCID: AUD criteria and tabak use disorder life time and last year \& acute depressive symptoms \& symptoms for Mania and psychotic disorder * Edinburgh Handedness Inventory (EHI) * Fagerström Test for Nicotine depend (FTND) * Barratt Impulsiveness Scale - Kurzversion (BIS-15) * Allgemeine Depressionsskala (ADS) * State-Trait-Anxiety Inventory (STAI-T) * Alcohol Use Disorders Identification Test (AUDIT) * Cannabis Use Disorder Identification Test (CUDIT) * CAS -A (Alkohol) * Fragebogen zur Sozialen Unterstützung (F-SozU K-14) * Oslo-3-Items-Social-Support Scale * Social Skills Rating System (SSRS) * Trier Inventory for chronic stress (TICS) * Rejection Sensitivity Questionnaires (RSQ-9) * Need to belong scale (NTBS) * Fragebogen zu Gedanken und Gefühlen (FGG-14) * Internationale Trauma Questionnaire (ITQ) * Zahlen-Symbol-Test (DST) * Wortschatztest (verbal intelligence)

  • Diagnostic testpre and post cyberball task

    Positive and Negative Affect Schedule(PANAS)

  • Diagnostic testVAS

    subjective arousal, subjective stress, valence, perceived ostracisms/loneliness

  • Diagnostic testafter cyberball task

    * Need Threat Scale * Manipulation check (VAS scale)

  • Behavioralsocial inclusion (Cyberball task)

    Social inclusion will be assessed using the cyberball paradigm: subjects will play an online game tossing a ball to each other with two more virtual co-players. Using a cover story, we make subjects believe that the co-players really exist and that they play a live online game. During social inclusion, ball tosses will be balanced between all three players.

06

What researchers measure

Primary outcomes

  1. Behavioral full-lever specific and general PIT (parallel version) effect day one

    Specific: Average percentage of alcohol choice difference during the presentation of alcohol or non-alcohol pavlovian background. General: Differences in number of button presses during the presentation of positive (+10 Euro) and negative (-10 Euro) pavlovian backgrounds.

    Time frame: Day 1

  2. Behavioral full-lever specific and general PIT (parallel version) effect day two

    Specific: Average percentage of alcohol choice difference during the presentation of alcohol or non-alcohol pavlovian background. General: Differences in number of button presses during the presentation of positive (+10 Euro) and negative (-10 Euro) pavlovian backgrounds.

    Time frame: Day 2

  3. Social exclusion/inclusion induced using Cyberball Game

    experimentally-induced social exclusion stress by using the cyberball paradigm: Subjects will play an online game tossing a ball to each other with two more virtual co-players. Using a cover story, we make subjects believe that the co-players really exist and that they play a live online game. During social exclusion, subjects will be systematically excluded by one co-player (partial exclusion), and during social inclusion, ball tosses will be balanced between all three players. Effects of the Cyberball manipulation (social exclusion/inclusion) will be assessed via ratings in Positive and Negative Affect Scale (PANAS) and Need-Threat-Scale (NTS).

    Time frame: Day 1

  4. Social exclusion/inclusion induced using Cyberball Game

    experimentally-induced social exclusion stress by using the cyberball paradigm: Subjects will play an online game tossing a ball to each other with two more virtual co-players. Using a cover story, we make subjects believe that the co-players really exist and that they play a live online game. During social exclusion, subjects will be systematically excluded by one co-player (partial exclusion), and during social inclusion, ball tosses will be balanced between all three players. Effects of the Cyberball manipulation (social exclusion/inclusion) will be assessed via ratings in Positive and Negative Affect Scale (PANAS) and Need-Threat-Scale (NTS).

    Time frame: Day 2

Secondary outcomes

  1. Concentration of cortisol in saliva

    \[Time Frame: Assessment before, during and after Cyberball game (T1: arrival of subject), T2: right before Cyberball game, T3: right after Cyberball game, T4: after PIT part 3 and T5: at the end of testing day)\]

    Time frame: Day 1 and Day 2

  2. Positive and Negative Affect Schedule (PANAS)

    Scale 1-5, for PA (positive affect) and NA (negative affect) higher scores indicate higher positive and negative affect

    Time frame: Baseline and after Cyberball Experiment on Day 1 and Day 2

  3. Need Threat Scale (NTS)

    Scale from 1 to 5, high scores indicate high needs in Belonging, Control, Meaningful existence and self-esteem

    Time frame: After Cyberball Experiment on Day 1 and Day 2

  4. Heart rate variability

    Time frame: At baseline 5 min AND During experimental part (social inclusion or exclusion) 5 min Day 1 and Day 2

07

Study locations

1 site
08

References and documents

Publications

  • Roayaee M, Rahman RA, Danziger M, Tudge L, Daedelow LS, Heinz A, Wustenberg T. [The others and I: How social interactions change the perception of other persons. The Cyberball paradigm and its indications in the migration context]. Fortschr Neurol Psychiatr. 2020 Feb;88(2):109-117. doi: 10.1055/a-1033-7304. Epub 2020 Feb 26. German. PubMed 32102102 ↗
  • Staebler K, Helbing E, Rosenbach C, Renneberg B. Rejection sensitivity and borderline personality disorder. Clin Psychol Psychother. 2011 Jul-Aug;18(4):275-83. doi: 10.1002/cpp.705. Epub 2010 May 25. PubMed 21110407 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2024; primary completion for Jun 2027, 32 months later.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 32 months is close to that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 11, 2024
First posted
Feb 13, 2024
StartEst.
Oct 1, 2024
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Aug 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06256952
Collaborators
Heidelberg University, Zentralinstitut für Seelische Gesundheit Mannheim, Technische Universität Dresden
Responsible party
Andreas Heinz (Prof., MD, PhD, Charite University, Berlin, Germany) — Principal investigator
First posted
Feb 13, 2024
Start date
Oct 1, 2024 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Aug 28, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion